array(3) { ["company_details"]=> array(13) { ["name"]=> string(14) "ELEKTA LIMITED" ["slug"]=> string(23) "dbe4b-gb-elekta-limited" ["logo"]=> string(84) "https://images.businessradar.com/linkedin_logos/03cdfb0f-1bfc-426b-afae-aad1f451dee7" ["description"]=> string(735) "At Elekta, our outcome-driven and cost-efficient solutions provide lasting clinical difference and are developed through sustainable environmental, social and governance practices. We’ve been working openly and proactively with clinicians and our partners for almost half a century to advance precision radiation therapy and meet continuously evolving patient needs—no matter where they are in the world. To us, it's personal, and our global team of 4,700 employees combine passion, science, and imagination to profoundly change cancer care. We don’t just build technology, we build hope. Elekta is headquartered in Stockholm, Sweden, with offices in 120 countries and listed on Nasdaq Stockholm. Visit elekta.com to learn more." ["address_street"]=> string(11) "Linac House" ["address_place"]=> string(7) "CRAWLEY" ["address_region"]=> NULL ["founding_date"]=> string(10) "1996-09-02" ["website_domain"]=> string(10) "elekta.com" ["website_url"]=> string(22) "https://www.elekta.com" ["industry_codes"]=> array(1) { [0]=> string(46) "Surgical and Medical Instruments and Apparatus" } ["employee_count"]=> int(820) ["article_count"]=> int(550) } ["articles"]=> array(4) { [0]=> array(7) { ["title_en"]=> string(75) "Elekta's report in line with the profit warning – pressured by currencies" ["snippet_en"]=> string(221) "Radiation therapy company Elekta, which issued a profit warning earlier in November, presents an ebita result for the second quarter of the broken fiscal year of SEK 539m, corresponding to an ebita margin of 14.5 percent." ["url"]=> string(85) "https://www.di.se/live/elektas-rapport-i-linje-med-vinstvarningen-pressas-av-valutor/" ["image_url"]=> string(78) "https://images.businessradar.com/articles/736b772a-72c4-42f6-8703-9563764e78a8" ["source"]=> string(5) "di.se" ["publication_date"]=> string(10) "2019-11-28" ["categories"]=> array(3) { [0]=> string(31) "Financial Update/Profit Warning" [1]=> string(24) "Quarterly/Annual Figures" [2]=> string(18) "Ecological Impacts" } } [1]=> array(7) { ["title_en"]=> string(79) "Elekta changes outlook for 2019/20 and addresses challenges related to COVID-19" ["snippet_en"]=> string(251) "Login Elekta changes outlook for 2019/20 and addresses challenges related to COVID-19 STOCKHOLM, April 28, 2020– As a result of the impact of the COVID-19 pandemic on our last quarter( ending April 30), Elekta( EKTA-B.ST) changes the outlook for the" ["url"]=> string(133) "https://www.elekta.com/pressreleases/DEF6F8EF8D5F4B0D/elekta-changes-outlook-for-2019-20-and-addresses-challenges-related-to-covid-19" ["image_url"]=> string(78) "https://images.businessradar.com/articles/4059d958-9a47-4bd3-8129-4be56f05215c" ["source"]=> string(10) "elekta.com" ["publication_date"]=> string(10) "2019-01-20" ["categories"]=> array(3) { [0]=> string(31) "Financial Update/Profit Warning" [1]=> string(8) "Epidemic" [2]=> string(18) "Ecological Impacts" } } [2]=> array(7) { ["title_en"]=> string(38) "Interim report May – January 2012/13" ["snippet_en"]=> string(253) "Interim report May – January 2012/13 · Order bookings increased 13* percent to SEK 8,080 M (7,186). · Net sales increased 11* percent to SEK 6,608 M (5,929). · Operating result amounted to SEK 873 M( 967) excluding non-recurring items of SEK -24 M(" ["url"]=> string(88) "https://www.elekta.com/pressreleases/A4ED6EE946F2D226/interim-report-may-january-2012-13" ["image_url"]=> string(78) "https://images.businessradar.com/articles/fc9dfa3d-87b7-4e68-a7c3-3bcbb2dc9a57" ["source"]=> string(10) "elekta.com" ["publication_date"]=> string(10) "2012-01-01" ["categories"]=> array(2) { [0]=> string(15) "Market Movement" [1]=> string(18) "Ecological Impacts" } } [3]=> array(7) { ["title_en"]=> string(73) "Elekta to accelerate revenue growth and sees continued strong EBIT growth" ["snippet_en"]=> string(249) "Stockholm 2011-06-08 Elekta to accelerate revenue growth and sees continued strong EBIT growth Elekta’s strategy will result in accelerated revenue growth and continued strong EBIT growth. This was the message from Tomas Puusepp, President" ["url"]=> string(139) "https://www.elekta.com/press/6290b78c-f8ce-4c4f-ba5b-44d8c7f7fd85/elekta-to-accelerate-revenue-growth-and-sees-continued-strong-ebit-growth" ["image_url"]=> string(78) "https://images.businessradar.com/articles/caa649fb-77da-4bac-bb07-7fc83620b2bf" ["source"]=> string(10) "elekta.com" ["publication_date"]=> string(10) "2011-06-08" ["categories"]=> array(4) { [0]=> string(24) "Quarterly/Annual Figures" [1]=> string(19) "New Revenue Streams" [2]=> string(18) "Ecological Impacts" [3]=> string(19) "Economic Conditions" } } } ["category_annotations"]=> array(30) { [0]=> array(2) { ["name"]=> string(13) "Collaboration" ["count"]=> int(35) } [1]=> array(2) { ["name"]=> string(11) "Acquisition" ["count"]=> int(25) } [2]=> array(2) { ["name"]=> string(24) "Quarterly/Annual Figures" ["count"]=> int(23) } [3]=> array(2) { ["name"]=> string(17) "Academic Research" ["count"]=> int(19) } [4]=> array(2) { ["name"]=> string(18) "Expansion & Growth" ["count"]=> int(16) } [5]=> array(2) { ["name"]=> string(5) "R & D" ["count"]=> int(16) } [6]=> array(2) { ["name"]=> string(15) "Market Movement" ["count"]=> int(15) } [7]=> array(2) { ["name"]=> string(12) "Stock Market" ["count"]=> int(14) } [8]=> array(2) { ["name"]=> string(5) "Award" ["count"]=> int(11) } [9]=> array(2) { ["name"]=> string(31) "Financial Update/Profit Warning" ["count"]=> int(11) } [10]=> array(2) { ["name"]=> string(15) "Deals & Tenders" ["count"]=> int(11) } [11]=> array(2) { ["name"]=> string(14) "Product Launch" ["count"]=> int(9) } [12]=> array(2) { ["name"]=> string(24) "Access and affordability" ["count"]=> int(8) } [13]=> array(2) { ["name"]=> string(12) "Board Change" ["count"]=> int(7) } [14]=> array(2) { ["name"]=> string(25) "Business Model Resilience" ["count"]=> int(6) } [15]=> array(2) { ["name"]=> string(18) "General Investment" ["count"]=> int(6) } [16]=> array(2) { ["name"]=> string(10) "Litigation" ["count"]=> int(6) } [17]=> array(2) { ["name"]=> string(12) "Going Public" ["count"]=> int(6) } [18]=> array(2) { ["name"]=> string(25) "Leadership and Governance" ["count"]=> int(5) } [19]=> array(2) { ["name"]=> string(10) "Executives" ["count"]=> int(5) } [20]=> array(2) { ["name"]=> string(5) "Event" ["count"]=> int(5) } [21]=> array(2) { ["name"]=> string(21) "Shareholders Feedback" ["count"]=> int(4) } [22]=> array(2) { ["name"]=> string(18) "Ecological Impacts" ["count"]=> int(4) } [23]=> array(2) { ["name"]=> string(12) "Staff hiring" ["count"]=> int(4) } [24]=> array(2) { ["name"]=> string(27) "Business Model & Innovation" ["count"]=> int(4) } [25]=> array(2) { ["name"]=> string(17) "Energy Management" ["count"]=> int(3) } [26]=> array(2) { ["name"]=> string(20) "Business Development" ["count"]=> int(3) } [27]=> array(2) { ["name"]=> string(5) "Legal" ["count"]=> int(3) } [28]=> array(2) { ["name"]=> string(20) "Corporate Governance" ["count"]=> int(2) } [29]=> array(2) { ["name"]=> string(21) "Intellectual Property" ["count"]=> int(2) } } } dbe4b-gb-elekta-limited

ELEKTA LIMITED

Location

Founded

1996-09-02

Website

https://www.elekta.com

Articles

550 Articles

Category

Surgical and Medical Instruments and Apparatus

Description

At Elekta, our outcome-driven and cost-efficient solutions provide lasting clinical difference and are developed through sustainable environmental, social and governance practices. We’ve been working openly and proactively with clinicians and our partners for almost half a century to advance precision radiation therapy and meet continuously evolving patient needs—no matter where they are in the world. To us, it's personal, and our global team of 4,700 employees combine passion, science, and imagination to profoundly change cancer care. We don’t just build technology, we build hope. Elekta is headquartered in Stockholm, Sweden, with offices in 120 countries and listed on Nasdaq Stockholm. Visit elekta.com to learn more.

Articles

Elekta's report in line with the profit warning – pressured by currencies

2019-11-28 (di.se)

Elekta's report in line with the profit warning – pressured by currencies

Radiation therapy company Elekta, which issued a profit warning earlier in November, presents an ebita result for the second quarter of the broken fiscal year of SEK 539m, corresponding to an ebita margin of 14.5 percent.

Read more
Elekta changes outlook for 2019/20 and addresses challenges related to COVID-19

2019-01-20 (elekta.com)

Elekta changes outlook for 2019/20 and addresses challenges related to COVID-19

Login Elekta changes outlook for 2019/20 and addresses challenges related to COVID-19 STOCKHOLM, April 28, 2020– As a result of the impact of the COVID-19 pandemic on our last quarter( ending April 30), Elekta( EKTA-B.ST) changes the outlook for the

Read more
Interim report May – January 2012/13

2012-01-01 (elekta.com)

Interim report May – January 2012/13

Interim report May – January 2012/13 · Order bookings increased 13* percent to SEK 8,080 M (7,186). · Net sales increased 11* percent to SEK 6,608 M (5,929). · Operating result amounted to SEK 873 M( 967) excluding non-recurring items of SEK -24 M(

Read more
Elekta to accelerate revenue growth and sees continued strong EBIT growth

2011-06-08 (elekta.com)

Elekta to accelerate revenue growth and sees continued strong EBIT growth

Stockholm 2011-06-08 Elekta to accelerate revenue growth and sees continued strong EBIT growth Elekta’s strategy will result in accelerated revenue growth and continued strong EBIT growth. This was the message from Tomas Puusepp, President

Read more

Newsletter subscription